Comparative expression of major histocompatibility complex (MHC) antigens on CD5+ and CD5− B cells in patients with chronic lymphocytic leukaemia (CLL)

This publication has 23 references indexed in Scilit:

• Induction of MHC antigens by tumour cell lines in response to interferons
  European Journal Of Cancer, 1992
• New views on rejection mechanisms and their relevance to interleukin-2 as a treatment for renal cell cancer
  European Journal of Cancer and Clinical Oncology, 1991
• Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma
  British Journal of Cancer, 1990
• Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.
  Proceedings of the National Academy of Sciences, 1989
• Loss of polymorphic A and B locus HLA antigens in colon carcinoma
  British Journal of Cancer, 1988
• Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
  Proceedings of the National Academy of Sciences, 1987
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.
  Journal of Clinical Pathology, 1981
• MHC-Restricted Cytotoxic T Cells: Studies on the Biological Role of Polymorphic Major Transplantation Antigens Determining T-Cell Restriction-Specificity, Function, and Responsiveness
  Published by Elsevier ,1979
• HLA restriction of cell-mediated lysis of influenza virus-infected human cells
  Nature, 1977